| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 70.76 | 10.9% |
| Total Income | 70.76 | 10.9% |
| Expenditure | 177.23 | 78.0% |
| PBT | — | |
| Net Profit | -111.03 | 367.7% |
| OPM | — | |
| NPM | — | |
| EPS | -1.53 | 337.1% |
Health Catalyst Reports Q1 2026 Results
12 May 2026 · 12 May, 1:48 am
Summary
Health Catalyst reported its financial results for the quarter ended March 31, 2026. The company's total revenue was $70.756 million. Adjusted EBITDA increased by 46% year-over-year to $9.137 million. The company is strategically resetting to focus on high-conviction technology opportunities. For the second quarter of 2026, Health Catalyst expects revenue between $68 million and $70 million and adjusted EBITDA between $9 million and $10 million. For the full year 2026, the company projects revenue of $260 million to $265 million and adjusted EBITDA of $30 million to $33 million.
Key Highlights
- 1
Health Catalyst reported total revenue of $70.756 million for the quarter ended March 31, 2026.
- 2
The company's adjusted EBITDA for Q1 2026 was $9.137 million, a 46% increase year-over-year.
- 3
Gross profit for the quarter was $27.726 million, representing a gross margin of 39%.
- 4
Adjusted gross profit was $36.439 million, resulting in an adjusted gross margin of 51%.
- 5
The company expects total revenue between $68 million and $70 million for the second quarter of 2026.
- 6
Health Catalyst anticipates adjusted EBITDA between $9 million and $10 million for Q2 2026.
- 7
For the full year 2026, the company projects total revenue of $260 million to $265 million and adjusted EBITDA of $30 million to $33 million.
Management Comments
Ben Albert
“We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations. More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed to build a more focused, durable Health Catalyst capable of meeting the opportunity in front of us. I am confident in the leadership team and board we have assembled to build the intelligence-driven technology company healthcare needs.”
Informational and educational content only. Not investment advice.